-
1
-
-
0037077308
-
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
-
V. Brinkmann, M.D. Davis, and C.E. Heise The immune modulator FTY720 targets sphingosine 1-phosphate receptors J Biol Chem 277 2002 21453 21457
-
(2002)
J Biol Chem
, vol.277
, pp. 21453-21457
-
-
Brinkmann, V.1
Davis, M.D.2
Heise, C.E.3
-
2
-
-
0037066466
-
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
-
S. Mandala, R. Hajdu, and J. Bergstrom Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296 2002 346 349
-
(2002)
Science
, vol.296
, pp. 346-349
-
-
Mandala, S.1
Hajdu, R.2
Bergstrom, J.3
-
5
-
-
78049480679
-
Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis
-
V. Brinkmann, A. Billich, and T. Baumruker Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat Rev Drug Discov 9 2010 883 897
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 883-897
-
-
Brinkmann, V.1
Billich, A.2
Baumruker, T.3
-
6
-
-
76149093586
-
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
-
L. Kappos, E.W. Radue, and P. O'Connor A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 2010 387 401
-
(2010)
N Engl J Med
, vol.362
, pp. 387-401
-
-
Kappos, L.1
Radue, E.W.2
O'Connor, P.3
-
7
-
-
76149140914
-
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
-
J.A. Cohen, F. Barkhof, and G. Comi Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis N Engl J Med 362 2010 402 415
-
(2010)
N Engl J Med
, vol.362
, pp. 402-415
-
-
Cohen, J.A.1
Barkhof, F.2
Comi, G.3
-
8
-
-
84901197534
-
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): A double-blind, randomised, placebo-controlled, phase 3 trial
-
P.A. Calabresi, E.W. Radue, and D. Goodin Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial Lancet Neurol 13 2014 545 556
-
(2014)
Lancet Neurol
, vol.13
, pp. 545-556
-
-
Calabresi, P.A.1
Radue, E.W.2
Goodin, D.3
-
9
-
-
85028102802
-
Early effect of fingolimod on clinical and MRI related outcomes in relapsing multiple sclerosis
-
P. Chin, P. Calabresi, and Y. Zhang Early effect of fingolimod on clinical and MRI related outcomes in relapsing multiple sclerosis Mult Scler 18 4 Suppl. 2012 459
-
(2012)
Mult Scler
, vol.18
, Issue.4
, pp. 459
-
-
Chin, P.1
Calabresi, P.2
Zhang, Y.3
-
10
-
-
85028100430
-
Fingolimod-effect on brain atrophy and clinical/MRI correlations in three phase 3 studies - TRANSFORMS, FREEDOMS and FREEDOMS II
-
[(Meeting Abstracts 1): S51.006]
-
J.A. Cohen, E.W. Radue, and F. Barkhof Fingolimod-effect on brain atrophy and clinical/MRI correlations in three phase 3 studies - TRANSFORMS, FREEDOMS and FREEDOMS II Neurology 80 2013 [(Meeting Abstracts 1): S51.006]
-
(2013)
Neurology
, vol.80
-
-
Cohen, J.A.1
Radue, E.W.2
Barkhof, F.3
-
11
-
-
70849086174
-
FTY720 (fingolimod) in multiple sclerosis: Therapeutic effects in the immune and the central nervous system
-
V. Brinkmann FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system Br J Pharmacol 158 2009 1173 1182
-
(2009)
Br J Pharmacol
, vol.158
, pp. 1173-1182
-
-
Brinkmann, V.1
-
12
-
-
1642580757
-
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
-
M. Matloubian, C.G. Lo, and G. Cinamon Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Nature 427 2004 355 360
-
(2004)
Nature
, vol.427
, pp. 355-360
-
-
Matloubian, M.1
Lo, C.G.2
Cinamon, G.3
-
14
-
-
3042750654
-
Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: Clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging
-
M. Rausch, P. Hiestand, and C.A. Foster Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging J Magn Reson Imaging 20 2004 16 24
-
(2004)
J Magn Reson Imaging
, vol.20
, pp. 16-24
-
-
Rausch, M.1
Hiestand, P.2
Foster, C.A.3
-
15
-
-
77951073508
-
Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis
-
J. Chun, and H.P. Hartung Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis Clin Neuropharmacol 33 2010 91 101
-
(2010)
Clin Neuropharmacol
, vol.33
, pp. 91-101
-
-
Chun, J.1
Hartung, H.P.2
-
16
-
-
35348970884
-
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
-
C.A. Foster, L.M. Howard, and A. Schweitzer Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis J Pharmacol Exp Ther 323 2007 469 475
-
(2007)
J Pharmacol Exp Ther
, vol.323
, pp. 469-475
-
-
Foster, C.A.1
Howard, L.M.2
Schweitzer, A.3
-
17
-
-
84959913458
-
Brain distribution of BZM055, an analog of fingolimod (FTY720), in humans
-
G. Tamagnan, A. Tavares, and O. Barret Brain distribution of BZM055, an analog of fingolimod (FTY720), in humans Mult Scler 18 4 Suppl. 2012 839
-
(2012)
Mult Scler
, vol.18
, Issue.4
, pp. 839
-
-
Tamagnan, G.1
Tavares, A.2
Barret, O.3
-
18
-
-
84876119766
-
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
-
A. Groves, Y. Kihara, and J. Chun Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy J Neurol Sci 328 2013 9 18
-
(2013)
J Neurol Sci
, vol.328
, pp. 9-18
-
-
Groves, A.1
Kihara, Y.2
Chun, J.3
-
19
-
-
80054052730
-
Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors
-
V.A. Blaho, and T. Hla Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors Chem Rev 111 2011 6299 6320
-
(2011)
Chem Rev
, vol.111
, pp. 6299-6320
-
-
Blaho, V.A.1
Hla, T.2
-
20
-
-
34250832664
-
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
-
V. Brinkmann Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology Pharmacol Ther 115 2007 84 105
-
(2007)
Pharmacol Ther
, vol.115
, pp. 84-105
-
-
Brinkmann, V.1
-
21
-
-
67449138784
-
Sphingosine-1-phosphate receptor signalling in the heart
-
C.K. Means, and J.H. Brown Sphingosine-1-phosphate receptor signalling in the heart Cardiovasc Res 82 2009 193 200
-
(2009)
Cardiovasc Res
, vol.82
, pp. 193-200
-
-
Means, C.K.1
Brown, J.H.2
-
22
-
-
0037162062
-
Lysophospholipids and the cardiovascular system
-
J.S. Karliner Lysophospholipids and the cardiovascular system Biochim Biophys Acta 1582 2002 216 221
-
(2002)
Biochim Biophys Acta
, vol.1582
, pp. 216-221
-
-
Karliner, J.S.1
-
23
-
-
11144353922
-
3, respectively, regulate lymphocyte recirculation and heart rate
-
3, respectively, regulate lymphocyte recirculation and heart rate J Biol Chem 279 2004 13839 13848
-
(2004)
J Biol Chem
, vol.279
, pp. 13839-13848
-
-
Sanna, M.G.1
Liao, J.2
Jo, E.3
-
24
-
-
10744230053
-
Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients
-
K. Budde, R.L. Scmouder, and B. Nashan Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients Am J Transplant 3 2003 846 854
-
(2003)
Am J Transplant
, vol.3
, pp. 846-854
-
-
Budde, K.1
Scmouder, R.L.2
Nashan, B.3
-
25
-
-
0038218405
-
Sphingosine-1-phosphate: An enigmatic signalling lipid
-
S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat Rev Mol Cell Biol 4 2003 397 407
-
(2003)
Nat Rev Mol Cell Biol
, vol.4
, pp. 397-407
-
-
Spiegel, S.1
Milstien, S.2
-
26
-
-
76149126108
-
Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning
-
T.H. Pham, P. Baluk, and Y. Xu Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning J Exp Med 207 2010 17 27
-
(2010)
J Exp Med
, vol.207
, pp. 17-27
-
-
Pham, T.H.1
Baluk, P.2
Xu, Y.3
-
28
-
-
1042278008
-
Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells
-
J. Harada, M. Foley, and M.A. Moskowitz Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells J Neurochem 88 2004 1026 1039
-
(2004)
J Neurochem
, vol.88
, pp. 1026-1039
-
-
Harada, J.1
Foley, M.2
Moskowitz, M.A.3
-
29
-
-
79958278811
-
The sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development
-
R.R. Poulsen, C.M. McClaskey, and S.A. Rivkees The sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development BMC Dev Biol 11 2011 37
-
(2011)
BMC Dev Biol
, vol.11
, pp. 37
-
-
Poulsen, R.R.1
McClaskey, C.M.2
Rivkees, S.A.3
-
30
-
-
84873836098
-
Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning
-
K. Mendelson, T. Zygmunt, and J. Torres-Vazquez Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning J Biol Chem 288 2013 2143 2156
-
(2013)
J Biol Chem
, vol.288
, pp. 2143-2156
-
-
Mendelson, K.1
Zygmunt, T.2
Torres-Vazquez, J.3
-
31
-
-
35048835160
-
Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase
-
M. Xu, C.L. Waters, and C. Hu Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase Am J Physiol Cell Physiol 293 2007 C1309 C1318
-
(2007)
Am J Physiol Cell Physiol
, vol.293
, pp. C1309-C1318
-
-
Xu, M.1
Waters, C.L.2
Hu, C.3
-
33
-
-
58149483374
-
Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature
-
J.F. Lee, S. Gordon, and R. Estrada Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature Am J Physiol Heart Circ Physiol 296 2009 H33 H42
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.296
, pp. H33-H42
-
-
Lee, J.F.1
Gordon, S.2
Estrada, R.3
-
35
-
-
34547915639
-
Attenuation of vascular permeability by methylnaltrexone: Role of mOP-R and S1P3 transactivation
-
P.A. Singleton, L. Moreno-Vinasco, and S. Sammani Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation Am J Respir Cell Mol Biol 37 2007 222 231
-
(2007)
Am J Respir Cell Mol Biol
, vol.37
, pp. 222-231
-
-
Singleton, P.A.1
Moreno-Vinasco, L.2
Sammani, S.3
-
36
-
-
0036905055
-
Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells
-
M. Graeler, and E.J. Goetzl Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells FASEB J 16 2002 1874 1878
-
(2002)
FASEB J
, vol.16
, pp. 1874-1878
-
-
Graeler, M.1
Goetzl, E.J.2
-
37
-
-
80355129639
-
4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model
-
4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model FASEB J 25 2011 4024 4036
-
(2011)
FASEB J
, vol.25
, pp. 4024-4036
-
-
Schulze, T.1
Golfier, S.2
Tabeling, C.3
-
38
-
-
85016365810
-
4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs
-
4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs Pulm Circ 1 2011 399 404
-
(2011)
Pulm Circ
, vol.1
, pp. 399-404
-
-
Ota, H.1
Beutz, M.A.2
Ito, M.3
-
39
-
-
13844271705
-
Edg8/S1P5: An oligodendroglial receptor with dual function on process retraction and cell survival
-
C. Jaillard, S. Harrison, and B. Stankoff Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival J Neurosci 25 2005 1459 1469
-
(2005)
J Neurosci
, vol.25
, pp. 1459-1469
-
-
Jaillard, C.1
Harrison, S.2
Stankoff, B.3
-
40
-
-
80855156707
-
Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking
-
K. Mayol, V. Biajoux, and J. Marvel Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking Blood 118 2011 4863 4871
-
(2011)
Blood
, vol.118
, pp. 4863-4871
-
-
Mayol, K.1
Biajoux, V.2
Marvel, J.3
-
41
-
-
2142851264
-
Lysophospholipid receptors: Signaling and biology
-
I. Ishii, N. Fukushima, and X. Ye Lysophospholipid receptors: signaling and biology Ann Rev Biochem 73 2004 321 354
-
(2004)
Ann Rev Biochem
, vol.73
, pp. 321-354
-
-
Ishii, I.1
Fukushima, N.2
Ye, X.3
-
42
-
-
0347481389
-
Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases
-
A. Billich, F. Bornancin, and P. Dévay Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases J Biol Chem 278 2003 47408 47415
-
(2003)
J Biol Chem
, vol.278
, pp. 47408-47415
-
-
Billich, A.1
Bornancin, F.2
Dévay, P.3
-
43
-
-
0344443651
-
Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability
-
T. Sanchez, T. Estrada-Hernandez, and J.H. Paik Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability J Biol Chem 278 2003 47281 47290
-
(2003)
J Biol Chem
, vol.278
, pp. 47281-47290
-
-
Sanchez, T.1
Estrada-Hernandez, T.2
Paik, J.H.3
-
44
-
-
0030656619
-
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
-
M. Uehata, T. Ishizaki, and H. Satoh Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension Nature 389 1997 990 994
-
(1997)
Nature
, vol.389
, pp. 990-994
-
-
Uehata, M.1
Ishizaki, T.2
Satoh, H.3
-
45
-
-
20944434884
-
Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3
-
M. Tölle, B. Levkau, and P. Keul Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3 Circ Res 96 2005 913 920
-
(2005)
Circ Res
, vol.96
, pp. 913-920
-
-
Tölle, M.1
Levkau, B.2
Keul, P.3
-
46
-
-
14644408845
-
The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I
-
L. Koyrakh, M.I. Roman, and V. Brinkmann The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I Am J Transplant 5 2005 529 536
-
(2005)
Am J Transplant
, vol.5
, pp. 529-536
-
-
Koyrakh, L.1
Roman, M.I.2
Brinkmann, V.3
-
48
-
-
16644394172
-
Endothelial cell barrier regulation by sphingosine 1-phosphate
-
B.J. McVerry, and J.G. Garcia Endothelial cell barrier regulation by sphingosine 1-phosphate J Cell Biochem 92 2004 1075 1085
-
(2004)
J Cell Biochem
, vol.92
, pp. 1075-1085
-
-
McVerry, B.J.1
Garcia, J.G.2
-
49
-
-
37849001331
-
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools
-
S. Salomone, E.M. Potts, and S. Tyndall Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools Br J Pharmacol 153 2008 140 147
-
(2008)
Br J Pharmacol
, vol.153
, pp. 140-147
-
-
Salomone, S.1
Potts, E.M.2
Tyndall, S.3
-
50
-
-
34247874512
-
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor agonists induce ubiquitinylation and proteasomal degradation of the receptor
-
M.L. Oo, S. Thangada, and M.T. Wu Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor agonists induce ubiquitinylation and proteasomal degradation of the receptor J Biol Chem 282 2007 9082 9089
-
(2007)
J Biol Chem
, vol.282
, pp. 9082-9089
-
-
Oo, M.L.1
Thangada, S.2
Wu, M.T.3
-
52
-
-
84856249964
-
Fingolimod for multiple sclerosis
-
D. Pelletier, and D.A. Hafler Fingolimod for multiple sclerosis N Engl J Med 366 2012 339 347
-
(2012)
N Engl J Med
, vol.366
, pp. 339-347
-
-
Pelletier, D.1
Hafler, D.A.2
-
53
-
-
84875367110
-
Fingolimod phosphate promotes the neuroprotective effects of microglia
-
H. Noda, H. Takeuchi, and T. Mizuno Fingolimod phosphate promotes the neuroprotective effects of microglia J Neuroimmunol 256 2013 13 18
-
(2013)
J Neuroimmunol
, vol.256
, pp. 13-18
-
-
Noda, H.1
Takeuchi, H.2
Mizuno, T.3
-
54
-
-
33747419124
-
Pulmonary and vascular pharmacology of sphingosine 1-phosphate
-
V. Brinkmann, and T. Baumruker Pulmonary and vascular pharmacology of sphingosine 1-phosphate Curr Opin Pharmacol 6 2006 244 250
-
(2006)
Curr Opin Pharmacol
, vol.6
, pp. 244-250
-
-
Brinkmann, V.1
Baumruker, T.2
-
55
-
-
11144355672
-
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes
-
M. Forrest, S.Y. Sun, and R. Hajdu Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes J Pharmacol Exp Ther 309 2004 758 768
-
(2004)
J Pharmacol Exp Ther
, vol.309
, pp. 758-768
-
-
Forrest, M.1
Sun, S.Y.2
Hajdu, R.3
-
58
-
-
0035374461
-
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells
-
M. Morales-Ruiz, M.J. Lee, and S. Zollner Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells J Biol Chem 276 2001 19672 19677
-
(2001)
J Biol Chem
, vol.276
, pp. 19672-19677
-
-
Morales-Ruiz, M.1
Lee, M.J.2
Zollner, S.3
-
59
-
-
2442699980
-
Sphingosine-1-phosphate receptors: Receptor specificity versus functional redundancy
-
T.A. Taha, K.M. Argraves, and L.M. Obeid Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy Biochim Biophys Acta 1682 2004 48 55
-
(2004)
Biochim Biophys Acta
, vol.1682
, pp. 48-55
-
-
Taha, T.A.1
Argraves, K.M.2
Obeid, L.M.3
-
60
-
-
34047253376
-
Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors
-
M. Osinde, F. Mullershausen, and K.K. Dev Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors Neuropharmacology 52 2007 1210 1218
-
(2007)
Neuropharmacology
, vol.52
, pp. 1210-1218
-
-
Osinde, M.1
Mullershausen, F.2
Dev, K.K.3
-
61
-
-
0037178737
-
Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: Differential role in vasoconstriction
-
F. Coussin, R.H. Scott, and A. Wise Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction Circ Res 91 2002 151 157
-
(2002)
Circ Res
, vol.91
, pp. 151-157
-
-
Coussin, F.1
Scott, R.H.2
Wise, A.3
-
62
-
-
0038730511
-
3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate
-
3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate Eur J Pharmacol 469 2003 125 134
-
(2003)
Eur J Pharmacol
, vol.469
, pp. 125-134
-
-
Salomone, S.1
Yoshimura, S.2
Reuter, U.3
-
63
-
-
4744340005
-
Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats
-
D.G. Hemmings, Y. Xu, and S.T. Davidge Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats Br J Pharmacol 143 2004 276 284
-
(2004)
Br J Pharmacol
, vol.143
, pp. 276-284
-
-
Hemmings, D.G.1
Xu, Y.2
Davidge, S.T.3
-
64
-
-
4644259224
-
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors
-
C. Waeber, N. Blondeau, and S. Salomone Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors Drug News Perspect 17 2004 365 382
-
(2004)
Drug News Perspect
, vol.17
, pp. 365-382
-
-
Waeber, C.1
Blondeau, N.2
Salomone, S.3
-
66
-
-
9644260561
-
The role of sphingosine-1-phosphate in smooth muscle contraction
-
K.R. Watterson, P.H. Ratz, and S. Spiegel The role of sphingosine-1-phosphate in smooth muscle contraction Cell Signal 17 2005 289 298
-
(2005)
Cell Signal
, vol.17
, pp. 289-298
-
-
Watterson, K.R.1
Ratz, P.H.2
Spiegel, S.3
-
68
-
-
33846405257
-
Sphingosine 1-phosphate causes airway hyper-reactivity by Rho-mediated myosin phosphatase inactivation
-
H. Kume, N. Takeda, and T. Oguma Sphingosine 1-phosphate causes airway hyper-reactivity by Rho-mediated myosin phosphatase inactivation J Pharmacol Exp Ther 320 2007 766 773
-
(2007)
J Pharmacol Exp Ther
, vol.320
, pp. 766-773
-
-
Kume, H.1
Takeda, N.2
Oguma, T.3
-
69
-
-
0036205659
-
First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients
-
K. Budde, R.L. Schmouder, and R. Brunkhorst First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients J Am Soc Nephrol 13 2002 1073 1083
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1073-1083
-
-
Budde, K.1
Schmouder, R.L.2
Brunkhorst, R.3
-
70
-
-
79955432850
-
-
[Accessed December 4, 2013]
-
Gilenya Summary of Product Characteristics http://www.medicines.org.uk/emc/medicine/24443/SPC 2013 [Accessed December 4, 2013]
-
(2013)
Gilenya Summary of Product Characteristics
-
-
-
73
-
-
0033572668
-
+ current diversity in mouse ventricular myocytes
-
+ current diversity in mouse ventricular myocytes J Physiol 521 1999 587 599
-
(1999)
J Physiol
, vol.521
, pp. 587-599
-
-
Guo, W.1
Xu, H.2
London, B.3
-
74
-
-
84938838488
-
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies
-
J.P. DiMarco, P. O'Connor, and J.A. Cohen First-dose effects of fingolimod: Pooled safety data from three phase 3 studies Mult Scler Relat Disord 3 2014 629 638
-
(2014)
Mult Scler Relat Disord
, vol.3
, pp. 629-638
-
-
Dimarco, J.P.1
O'Connor, P.2
Cohen, J.A.3
-
75
-
-
0036151570
-
The role of muscarinic K(+) channels in the negative chronotropic effect of a muscarinic agonist
-
M. Yamada The role of muscarinic K(+) channels in the negative chronotropic effect of a muscarinic agonist J Pharmacol Exp Ther 300 2002 681 687
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 681-687
-
-
Yamada, M.1
-
76
-
-
84867319781
-
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
-
P. Gergely, B. Nuesslein-Hildesheim, and D. Guerini The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate Br J Pharmacol 16 2012 1035 1047
-
(2012)
Br J Pharmacol
, vol.16
, pp. 1035-1047
-
-
Gergely, P.1
Nuesslein-Hildesheim, B.2
Guerini, D.3
-
77
-
-
84860167748
-
Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients
-
J.B. Moberly, D.M. Ford, and H. Zahir Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients J Neuroimmunol 246 2012 100 107
-
(2012)
J Neuroimmunol
, vol.246
, pp. 100-107
-
-
Moberly, J.B.1
Ford, D.M.2
Zahir, H.3
-
78
-
-
0036239322
-
Cell type-specific localization of human cardiac S1P receptors
-
D. Mazurais, P. Robert, and B. Gout Cell type-specific localization of human cardiac S1P receptors J Histochem Cytochem 50 2002 661 670
-
(2002)
J Histochem Cytochem
, vol.50
, pp. 661-670
-
-
Mazurais, D.1
Robert, P.2
Gout, B.3
-
79
-
-
0033615537
-
Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate
-
M.J. Lee, S. Thangada, and K.P. Claffey Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate Cell 99 1999 301 312
-
(1999)
Cell
, vol.99
, pp. 301-312
-
-
Lee, M.J.1
Thangada, S.2
Claffey, K.P.3
-
80
-
-
33845949505
-
Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family
-
P.A. Singleton, S.M. Dudek, and S.F. Ma Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family J Biol Chem 281 2006 34381 34393
-
(2006)
J Biol Chem
, vol.281
, pp. 34381-34393
-
-
Singleton, P.A.1
Dudek, S.M.2
Ma, S.F.3
-
82
-
-
2542461296
-
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury
-
X. Peng, P.M. Hassoun, and S. Sammani Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury Am J Respir Crit Care Med 169 2004 1245 1251
-
(2004)
Am J Respir Crit Care Med
, vol.169
, pp. 1245-1251
-
-
Peng, X.1
Hassoun, P.M.2
Sammani, S.3
-
83
-
-
85028116144
-
Peripheral and Central Nervous System Drugs Advisory Committee Meeting
-
[Accessed December 4, 2013]
-
Peripheral and Central Nervous System Drugs Advisory Committee Meeting Fingolimod (NDA 22-527) Background Package http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drudr/peripheralandcentralnervoussystemdrugsadvisorycommittee/ucm214670.pdf 2010 [Accessed December 4, 2013]
-
(2010)
Fingolimod (NDA 22-527) Background Package
-
-
-
84
-
-
58449114090
-
Diabetic macular edema: Pathogenesis and treatment
-
N. Bhagat, R.A. Grigorian, and A. Tutela Diabetic macular edema: pathogenesis and treatment Surv Ophthalmol 54 2009 1 32
-
(2009)
Surv Ophthalmol
, vol.54
, pp. 1-32
-
-
Bhagat, N.1
Grigorian, R.A.2
Tutela, A.3
-
85
-
-
84879798337
-
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis
-
M.A. Zarbin, L.M. Jampol, and R.D. Jager Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis Ophthalmology 120 2013 1432 1439
-
(2013)
Ophthalmology
, vol.120
, pp. 1432-1439
-
-
Zarbin, M.A.1
Jampol, L.M.2
Jager, R.D.3
-
86
-
-
84895501035
-
Position and practical use of fingolimod in Europe
-
G. Comi Position and practical use of fingolimod in Europe Clin Exp Neuroimmunol 5 2014 19 33
-
(2014)
Clin Exp Neuroimmunol
, vol.5
, pp. 19-33
-
-
Comi, G.1
-
88
-
-
84899118363
-
Fingolimod treatment initiation experience: Cardiac and Holter electrocardiogram findings from three phase 3 studies
-
J. DiMarco, P. O'Connor, and J.A. Cohen Fingolimod treatment initiation experience: cardiac and Holter electrocardiogram findings from three phase 3 studies Mult Scler 18 4 Suppl. 2012 55 277
-
(2012)
Mult Scler
, vol.18
, Issue.4
, pp. 55-277
-
-
Dimarco, J.1
O'Connor, P.2
Cohen, J.A.3
-
89
-
-
84895445228
-
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study
-
R. Gold, G. Comi, and J. Palace Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study J Neurol 261 2 2014 267 276
-
(2014)
J Neurol
, vol.261
, Issue.2
, pp. 267-276
-
-
Gold, R.1
Comi, G.2
Palace, J.3
-
90
-
-
84899650421
-
Cardiac effects of fingolimod after first dose administration and therapy change in patients with multiple sclerosis
-
[Meeting Abstracts 1:P01.170]
-
B. Hughes, M. Cascione, and K. McCague Cardiac effects of fingolimod after first dose administration and therapy change in patients with multiple sclerosis Neurology 80 2013 [Meeting Abstracts 1:P01.170]
-
(2013)
Neurology
, vol.80
-
-
Hughes, B.1
Cascione, M.2
McCague, K.3
-
91
-
-
84899660109
-
Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial
-
A. Laroni, D. Brogi, and V.B. Morra Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial BMC Neurol 14 2014 65
-
(2014)
BMC Neurol
, vol.14
, pp. 65
-
-
Laroni, A.1
Brogi, D.2
Morra, V.B.3
-
92
-
-
33745927144
-
FTY720: Placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects
-
R. Schmouder, D. Serra, and Y. Wang FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects J Clin Pharmacol 46 2006 895 904
-
(2006)
J Clin Pharmacol
, vol.46
, pp. 895-904
-
-
Schmouder, R.1
Serra, D.2
Wang, Y.3
-
93
-
-
85028113682
-
Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly treated with serotonin specific reuptake inhibitors
-
R. Bermel, R. Hashmonay, and X. Meng Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly treated with serotonin specific reuptake inhibitors Mult Scler 19 11 Suppl. 2013 74 558
-
(2013)
Mult Scler
, vol.19
, Issue.11
, pp. 74-558
-
-
Bermel, R.1
Hashmonay, R.2
Meng, X.3
-
94
-
-
84880391860
-
Initiating oral fingolimod treatment in patients with multiple sclerosis
-
B.A. Singer Initiating oral fingolimod treatment in patients with multiple sclerosis Ther Adv Neurol Disord 6 2013 269 275
-
(2013)
Ther Adv Neurol Disord
, vol.6
, pp. 269-275
-
-
Singer, B.A.1
|